腹水原因解析

doi:10.3969/j.issn.1672-5069.2018.05.001

Abstract

Cui Ruibing, Yan Ming.. Etiology of ascites:what’s going on[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 657-660.

[1] Oey RC,van Buuren HR,de Man RA. The diagnostic work-up in patients with ascites:current guidelines and future prospects. Neth J Med,2016,74(8):330-335.
[2] Senousy BE,Dragnov PV.Evaluation and management of patients with refractory ascites. World J Gastroenterol,2009,15:67-80.
[3] Biecker E.Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol,2011,17:1237-1248.
[4] Bendtsen F,Grnbaek H,Hansen JB,et al.Treatment of ascites and spontaneous bacterial peritonitis-Part I. Dan Med J,2012,59:C4371.
[5] Moore KP,Wong F,Gines P,et al.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club. Hepatology,2003,38:258-266.
[6] Gine SP,Cardenas A.The management of ascites and hyponatremia in cirrhosis. Semin Liver Dis,2008,28:43-58.
[7] Cardenas A,Gines P.Management of refractory ascites. Clin Gastroenterol Hepatol,2005,3:1187-1191.
[8] Planas R,Montoliu S,Balleste B,et al.Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol,2006,4:1385-1394.
[9] Atkinson M,Losowsky MS.The mechanism of ascites for mation in chronic liver disease. Q J Med,1961,30:153-66.
[10] Sherlock A,Shaldon S.The aetiology and management of ascites in patients with hepatic cirrhosis:a review. Gut,1963,4:95-105.
[11] Bosch J,Abraldes JG,Berzigotti DA,et al.Portal hypertension and gastrointestinal bleeding. Semin Liver Dis,2008,28:3-25.
[12] Iwakiri Y,Groszmann RJ.The hyperdynamic circulation of chronic liver diseases:from the patient to the molecule. Hepatology,2006,43:S121-31.
[13] Ros J,Claria J,To-Figueras SJ,et al.Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure and experimental cirrhosis in the rat. Gastroenterology,2002,122:85-93.
[14] Schrier RW,Arroyo V,Ber nardi M,et al. Peripheral arterial vasodilation hypothesis:a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology,1988,8:1151-1157.
[15] Cannaziga M,Salerno F,Vistentin S,et al.Increased flow-mediated vasodilation in cirrhotic patients with ascites:relationship with renal resistant index. Liver Int,2008,28:1396-1401.
[16] Rasaratnam B,Kaye D,Jennings G,et al.The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis:a randomized trial. Ann Intern Med,2003,139:186-193.
[17] Gordon FD.Ascites. Clin Liver Dis,2012,16:285-299.
[18] Plessier A,Darwish-Murad S,Hernandez-Guerra M,et al.Acute portal vein thrombosis unrelated to cirrhosis:a prospective multicenter follow-up study. Hepatology,2010,51:210-218.
[19] 何焕然,黎明,魏东平,等. 晚期血吸虫病难治性腹水治疗的对照研究. 中国血吸虫病防治杂志,2012,24(5):570-572.
[20] Plessier A.Budd-Chiari syndrome. Rev Med Interne,2013,34:741-745.
[21] 黄晓明,杨玲,郭晖,等. 肝小静脉闭塞症10例临床分析. 中西医结合肝病杂志,2011,21(5):280-281.
[22] Runyon BA,Montano AA,Akriviadis EA,et al.The serum-ascites albumin gradient is superior to the exudates transudate concept in the differential diagnosis of ascites. Ann Intern Med,1992,117:215-220.
[23] 张秀春. 173例恶性腹水病因及临床特点分析. 中国当代医药,2010,17(21):173.
[24] Ayantunde AA,Parsons SL.Pattern and prognostic factors in patients with malignant ascites:a retrospective study. Ann Oncol,2007,18:945-949.
[25] Tamsma JT,Keizer HJ,Meinders AE.Pathogenesis of malignant ascites:Starling’s law of capillary hemodynamics revisited. Ann Oncol,2001,12:13537.
[26] Mesiano S, Ferrara N,Jaffe RB.Role of vascular endothelial growth factor in ovarian cancer:inhibition of ascites formation by immunoneutralization. Am J Pathol,1998,153:1249-1256.
[27] Sharma H,Bell I,Schofield J,et al.Primary peritoneal mesothelioma:case series and literature review. Clin Res Hepatol and Gastroenterol,2011,35:55-59.
[28] Ronnett BM,Zahn CM,Kurman RJ,et al.Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features,site of origin,prognosis,and relationship to“pseudo-myxoma peritonei”. Am J Surg Pathol,1995,19:1390-1408.
[29] Hammond TC,Takiyyuddin MA.Nephrogenic ascites:a poorly understood syndrome. J Am Soc Nephrol,1994,5:1173-1177.
[30] Marshall JB.Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol,1993,88:989-999.
[31] Shafer RW,Kim DS,Weiss JP,et al.Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore),1991,70:384-397.
[32] Patel KC.Filariasis,chyluria and chylous effusion. J Assoc Physicians India,1983,31:801-803.
[33] Parolini I,Blanc P,Larrey D.Bacterial perihepatitis. Rev Prat,2001,51:2081-2085.
[34] Marbet UA,Stalder GA,Vgtlin J,et al.Diffuse peritonitis and chronic ascites due to infection with Chlamydia trachomatis in patients without liver disease:new presentation of the Fitz-Hugh-
Curtis syndrome. Br Med J Clin Res Ed,1986,293:5-6.
[35] Mok CC.Investigation sand management of gastrointestinal and hepatic manifestations of systemic lupus erythematosus. Best Pract Res Clin Rheumatol,2005,19:741-766.
[36] Chowdhary VR,Crowson CS,Poterucha JJ,et al.Liver involvement in systemic lupus erythematosus:case review of 40 patients. J Rheumatol,2008,35:2159-2164.
[37] Bhardwaj R,Vaziri H,Gautam A,et al.Chylous ascites:A review of pathogenesis,diagnosis and treatment. J Clin Transl Hepatol,2018,6(1):105-113.
[38] Brown MW,Berk RF.Development of intractable ascites following upper abdominal surgery in patients with cirrhosis. Am J Gastroenterol,1986,80:879-883.
[39] Miedema EB,Bissada NK,Finkbeiner H,et al.Chylous ascites complicating retroperitoneal lymphadenectomy for testis tumors:management with peritoneovenous shunting. J Urol,1978,120:377-382.
[40] Steinemann DC,Dindo D,Clavien PA,et al.Atraumatic chylous ascites:systematic review on symptoms and causes. J Am Coll Surg,2011,212:899-905.
[41] Rector WG.Spontaneous chylous ascites of cirrhosis. J Clin Gastroenterol,1984,6:369-372.
[42] Hurst PA,Edwards JM.Chylous ascites and obstructive lymphoedema of the small bowel following abdominal radiotherapy. Br J Surg,1979,66:780-781.
[43] Francis M,Badero OO,Borowsky M,et al.Pericardial effusion,right-sided pleural effusion and ascites associated with stage IV endometriosis. A case report. J Reprod Med,2003,48:463-465.
[44] Fortier D,Dedecker F,Gabriele M,et al.Endometriosis with ascites and pleural effusion:a case report. Gynecol Obstet Fertil,2005,33:508-510.
[45] McElhinney B,McClure N. Ovarian hyperstimulation syndrome. Baillieres Best Pract Res Clin Obstet Gynaecol,2000,14:103-122.
[46] Carrier P,Jacques J, Debette-Gratien M,et al.Non-cirrhotic ascites:Pathophysiology,diagnosis and etiology. La Revue de me decine Interne,2014,35:365-371.

Etiology of ascites:what’s going on

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Ding Limin, Wang Fei, Piao Lianshu, et al.. Etiology of 202 patients with abnormal liver function tests [J]. Journal of Practical Hepatology, 2019, 22(6): 856-859.
[3]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[4]	Hu Hulan, Zhu Mengfei, Shi Junping.. Non-alcoholic fatty liver disease with concurrent chronic hepatitis B: What’s the progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 149-152.
[5]	Liang Jing, Han Tao.. Highlights of diagnosis and evaluation of ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 661-664.
[6]	Li Yue, Ding Huiguo.. Current diagnosis and treatment of chylous ascites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 665-668.
[7]	Chen Shiyao, Huang Xiaoquan, Ceng Xiaoqing. Etiology and diagnosis of portal hypertension [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 321-324.
[8]	Zhang Yanhong, Li You, Chen Long, et al. Etiology and complications in 2890 patients with liver cihhrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 344-347.
[9]	Liu Honghong, Zhao Ping. Insight of diagnosis and treatment of ascites in cirrhotics with integrated traditional Chinese and western medicine [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 485-488.
[10]	Zeng Minde. Mechanisms of lipotoxicity in pathogenesis of nonalcoholic fatty liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 153-156.
[11]	Chen Xiaoqing, Wang Yinchun. Etiology and treatment of intrahepatic cholestatic liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 163-165.
[12]	Chi Zhaochun. Pathogenesis of nonalcoholic steatohepatitis and cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 166-169.
[13]	Wang Peiwen, Dong Yuwei, Li Zhenghong, et al. Clinicopathological analysis of 94 patients with unexplained abnormal liver function tests [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 225-228.
[14]	Xin Fengzhi, Cao Haixia, Fan Jiangao. Glucagon-like peptide-1 in melioration of non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 313-316.
[15]	. Guidelines on the management of ascites and complications in cirrhosis Chinese Society of Hepatology, Chinese Medical Association [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 21-31.